ArticleThe oncologist2025
Concurrent local therapy extends clinical benefit of tebentafusp in metastatic uveal melanoma patients.
Tristan L Lim et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it